|
Rohit Mehta has over 18 years of experience in a broad range of global business and corporate development, including licensing, M&A due diligence, joint ventures, product acquisitions, start-ups, API sourcing, early- and late-stage technology assessment, project development, and company and industry analyses.
Prior to joining Iroko Pharmaceuticals, Mr. Mehta was a principal in Jay Consulting, a firm providing business and corporate development consulting to venture capital, drug delivery, and biotechnology and pharmaceutical companies in the US and Asia. Before that, he held a number of senior- and middle-level management positions, including Vice President of Corporate Development at Dr. Reddy's Laboratories (US) and EpiCept Corporation, and as Director of Business Development at Endo Pharmaceuticals.
Mr. Mehta serves on the IRB and IBC committees at Temple University. | 